Palatin Technologies Inc (PTN)

0.51 +0.01  +1.98% NYSE AM Jul 28, 16:59 USD
View Full Chart
Price Chart
View All PTN News


View All Events


Date Type Description
09/28/2021 Earnings Results Q4 2021 Earnings Results
09/28/2021 11:00 EST Earnings Calls Q4 2021 Earnings Call
06/08/2021 09:00 EST AGM 2020 Annual General Meeting
05/17/2021 Earnings Results Q3 2021 Earnings Results
05/17/2021 11:00 EST Earnings Calls Q3 2021 Earnings Call
02/17/2021 Earnings Results Q2 2021 Earnings Results
02/17/2021 11:00 EST Earnings Calls Q2 2021 Earnings Call
11/17/2020 11:00 EST Earnings Calls Q1 2021 Earnings Call
11/17/2020 Earnings Results Q1 2021 Earnings Results
09/28/2020 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Sep. 28, 2021
  • Last Earnings Release: May. 17, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.